Special issues will be covering a specific theme in new and emerging areas of discipline in Immunology. All submissions will undergo anonymous review to guarantee high scientific quality and relevance to the subject. For any inquiries related to a Special Issue, please contact the Editorial Office.
Clade 1b Mpox – Advances in Research and Public Health Responses
Submission deadline Dec 20 2024 | 0
This special issue explores the latest advancements in understanding Clade 1b Mpox, including its genetic evolution, epidemiology, and public health challenges. The issue invites cutting-edge research on diagnostics, treatments, vaccines, and policy responses to enhance global strategies against this variant. Contribute your insights to shape future public health initiatives.
Keywords : Clade 1b Mpox, Mpox research, public health, epidemiology, genetic evolution, diagnostics, treatments, vaccines, outbreak response, public health policy, immunology, viral infections, global health.Advances in Mucosal Immunology
Submission deadline Dec 30 2024 | 0
Explore cutting-edge research on the mucosal immune system's role in health and disease. This issue covers immune mechanisms, mucosal vaccines, microbiota interactions, immunopathology, therapeutic interventions, clinical applications, and case studies.
Keywords : Mucosal immunology, immune mechanisms, vaccines, microbiota, immunopathology, therapeutic interventions, clinical applicationsAutoimmune Diseases: Mechanisms, Diagnosis, and Treatment
Submission deadline Oct 01 2024 | 0
Explore the latest advancements in autoimmune disease research with our special issue. Discover insights into the genetic, environmental, and molecular mechanisms of autoimmunity, innovative diagnostic tools, novel therapeutic approaches, and detailed case studies. This collection aims to enhance understanding and treatment of autoimmune diseases, contributing to improved patient outcomes. Researchers are invited to submit their original articles, reviews, and clinical reports.
Keywords : Autoimmunity, Genetic Susceptibility, Biomarkers, Diagnostic Innovations, Therapeutic Strategies, Clinical Trials, Immunomodulation, and Patient Outcomes.COVID-19 and Immunological Responses
Submission deadline Oct 01 2024 | 0
The Journal of Immunological Sciences is launching a special issue on "COVID-19 and Immunological Responses" to compile cutting-edge research on the immune mechanisms and responses to SARS-CoV-2. This issue will focus on advancements in understanding immune responses, vaccine development, long COVID, and immune evasion strategies, aiming to provide comprehensive insights into the immunology of COVID-19.
Keywords : COVID-19, SARS-CoV-2, Immune response, Vaccine development, Long COVID, Immune evasion, Immunopathology, Therapeutic interventions, Immunomodulation, Respiratory viruses, Variants, Vaccine efficacy, Immunology, Infectious diseases, Viral immunologyAdvanced Immunological Monitoring in Skin Health and Diseases
Submission deadline Sep 30 2024 | 0
This issue aims to feature groundbreaking research and reviews on the role of immune cells, cytokines, and biomarkers in the diagnosis, monitoring, and treatment of skin diseases.
Keywords : Immune Monitoring, Cytokines in Skin Diseases, Immunological Biomarkers, Skin Immunology, Chronic Skin Conditions, Dermatological Immunotherapy, Skin Cancer Immunology, Psoriasis and Eczema Immunology, Innovations in Immune Monitoring, Single-Cell Transcriptomics, Biologics in Dermatology, Cutaneous Immune Response, Immunological Techniques, Advanced Therapies in Dermatology, Inflammatory Skin Diseases, Dermatological Research, Flow Cytometry in Dermatology, Immune Cell Profiling, Skin Disease Pathogenesis, Translational Dermatology Research.Advances in Cancer Immunotherapy
Submission deadline Sep 30 2024 | 0
This special issue on cancer immunotherapy explores cutting-edge research and clinical applications that harness the immune system to fight cancer. Topics include immune checkpoint inhibitors, CAR-T cell therapy, tumor-infiltrating lymphocytes, cancer vaccines, oncolytic viruses, combination therapies, and biomarkers for immunotherapy response. It also addresses mechanisms of immune resistance, novel immunotherapeutic targets, and precision medicine in immunotherapy. This issue aims to provide a comprehensive overview of advancements in immuno-oncology, offering insights into both preclinical studies and clinical trials, with a focus on enhancing antitumor immunity and overcoming therapeutic challenges.
Keywords : Cancer Immunotherapy, Immune Checkpoint Inhibitors, CAR-T Cell Therapy, Tumor-Infiltrating Lymphocytes (TILs), Cancer Vaccines, Oncolytic Viruses, and Combination Therapies. It also focuses on Immunotherapy Biomarkers, Immune Resistance Mechanisms, Novel Immunotherapeutic Targets, Immuno-Oncology, and Precision Medicine in Immunotherapy. Other important areas include Immune Evasion, Clinical Trials in Immunotherapy, Adoptive Cell Transfer, Cytokine Therapy, Checkpoint Blockade, Immune Modulation, Antitumor Immunity, and Translational Immunotherapy. The issue explores Immunogenic Cell Death, Immune-Related Adverse Events, Neoantigens, Tumor Microenvironment, PD-1/PD-L1 Inhibitors, CTLA-4 Inhibitors, Immune Surveillance, Personalized Cancer Therapy, Immunotherapy Response, and Preclinical Immunotherapy Studies.Mpox Outbreaks in Africa: Immunological Perspectives, Epidemiology, and Public Health Challenges
Edited By Dr. Joseph Chukwudi Okeibunor
Submission deadline Sep 30 2024 | 0
Dr. Joseph Chukwudi Okeibunor
Researcher at World Health Organization Brazzaville, Republic of the Congo
Keywords : Mpox, Clade 1b Mpox, Immunology, Sexual transmission, Human-to-human transmission, Global outbreak, Clade I, Clade IIb, Zoonotic transmission, Diagnostics, Epidemiology, Public health, Africa, Monkeypox virus, Viral transmission, Immune responseSocial And Anthropological Dimensions Of Response To Ebola Outbreak In Ituri And North Kivu, Democratic Republic Of Congo
Submission deadline Oct 30 2023 | 12 Articles
World Health Organization
Switzerland
Keywords : Therapeutic itinerary; Modern medicine; Treatment; Ebola survivors.Response to Polio Virus Disease Outbreaks in the Horn of Africa and Lake Chad Basin
Submission deadline Nov 10 2020 | 17 Articles
Polio Eradication Programme
WHO Regional Office for Africa
Brazzaville, Congo
Immunization and Vaccine Development by WHO Regional Office for Africa
Submission deadline May 01 2018 | 22 Articles
Immunization is widely recognized as a proven tool for controlling and possibly eradicating disease and remains one of the most cost effective public health interventions. Infectious agents such as viruses, bacteria and parasites are responsible for the major childhood diseases (e.g. viruses cause measles and polio while bacteria cause tetanus, diphtheria and pertussis).
Keywords : Immunization; Vaccine Development